Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction

Background Although intravenous (IV) bisphosphonates are first-line medications for the management of hypercalcemia, studies examining their use in patients with preexisting renal dysfunction are limited. Objective The objective of this study is to describe the safety and efficacy of pamidronate and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Annals of pharmacotherapy 2021-03, Vol.55 (3), p.303-310
Hauptverfasser:	Palmer, Shannon, Tillman, Frank, Sharma, Preetika, Auten, Jessica, Owen, Kathryn, Clark, Stephen M., Morgan, Katherine P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Adult Aged Aged, 80 and over Diphosphonates - pharmacology Diphosphonates - therapeutic use Female Humans Hypercalcemia - drug therapy Kidney Diseases - chemically induced Male Middle Aged Prospective Studies Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!